Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
ABP52497 Theaflavin TF3 Relieves Hepatocyte Lipid Deposition through Activating an AMPK Signaling Pathway by targeting Plasma Kallikrein(ABP52497-4) 4 JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
KTB1123 CheKine™ Micro Hexokinase (HK) Activity Assay Kit Theaflavin 3, 3′-digallate stabilizes vulnerable plaques by reprogramming metabolic homeostasis in neovascularization via HK2/TIGAR.(KTB1123-8.3) 8.3  Phytomedicine 
A21010 HRP, Goat Anti-Mouse IgG Therapeutic effect of nicotinamide mononucleotide on Alzheimer's disease through activating autophagy and anti-oxidative stress(A21010-7.5) 7.5 Veterinary Microbiology
ABL1020 Anti-GAPDH Mouse Monoclonal Antibody (2B5) Therapeutic effects of exendin‐4 on spinal cord injury via restoring autophagy function and decreasing necroptosis in neuron(ABL1020-5) 5 Sci Rep
A21010 HRP, Goat Anti-Mouse IgG Therapeutic effects of total saikosaponins from Radix bupleuri against Alzheimer's disease(A21010-4.8) 4.8 Poultry Science 
A21020 HRP, Goat Anti-Rabbit IgG Therapeutic effects of total saikosaponins from Radix bupleuri against Alzheimer's disease(A21020-4.8) 4.8 Advanced Healthcare Materials 
KTD3001 Protein Quantification Kit (BCA Assay) Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy …(KTD3001-7.1) 7.1 Environmental Toxicology and Chemistry
ABM0079 Beclin-1 Mouse Monoclonal Antibody (5C2) Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model(ABM0079-8) 8 Stem cell research & therapy
BMU102 Therapeutic potential of CHI3L1 in osteoarthritis: Inhibition of cartilage matrix degradation and inflammation through TLR4-MAPK-STAT1 pathway.(BMU102-4.7) 4.7  International Immunopharmacology
KTD104 Therapeutic Potential of IL‐37 in Cervical Cancer: Suppression of Tumour Progression and Enhancement of CD47‐Mediated Macrophage Phagocytosis.(KTD104-3.2) 3.2 Molecular Carcinogenesis